Ms. Sukanya Choudhury has resumed her position as Executive Vice President – Regulatory Affairs at GlaxoSmithKline after completing her secondment in a global role, effective October 29, 2025. This change is part of the company’s senior management adjustments, ensuring continued leadership in regulatory affairs. The announcement confirms her return, with no other significant details provided.
Executive Leadership Update
GlaxoSmithKline (GSK) announced the return of Ms. Sukanya Choudhury to her former role after a period of international assignment. As of October 29, 2025, she has officially resumed her responsibilities as Executive Vice President – Regulatory Affairs.
Details of Personnel Change
Ms. Choudhury successfully completed her secondment in a global capacity and has transitioned back to her original position within the company. This adjustment ensures continuity in GSK’s leadership structure and strategic direction regarding regulatory matters.
Additional Information
Key details related to this change include the completion of a global secondment. Ms. Choudhury is now back in her role, effectively continuing her prior responsibilities.
Source: BSE
